Welcome to our dedicated page for Crescent Cap Bdc SEC filings (Ticker: FCRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Crescent Cap Bdc's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Crescent Cap Bdc's regulatory disclosures and financial reporting.
Crescent Capital BDC, Inc. reported lower results for the year ended December 31, 2025, with net investment income of $1.81 per share and net income of $0.93 per share, down from $2.40 and $1.99 per share in 2024. Investment income fell to $167.3 million from $197.4 million, mainly because benchmark interest rates declined and certain debt investments were restructured. Net asset value per share declined to $19.10 from $19.98 as credit marks and foreign currency hedges weighed on results. For the fourth quarter of 2025, net investment income was $0.45 per share and net income was $0.23 per share. The company’s board declared a regular cash dividend of $0.42 per share for the first quarter of 2026, payable April 15, 2026 to shareholders of record on March 31, 2026. At year-end, Crescent BDC held $1.57 billion of investments across 184 portfolio companies, a weighted average yield on income-producing securities of 10.0%, and a debt-to-equity ratio of 1.25x, supported by $31.5 million of cash and $242.0 million of undrawn credit capacity.
Crescent Capital BDC, Inc. reported lower results for the year ended December 31, 2025, with net investment income of $1.81 per share and net income of $0.93 per share, down from $2.40 and $1.99 per share in 2024. Investment income fell to $167.3 million from $197.4 million, mainly because benchmark interest rates declined and certain debt investments were restructured. Net asset value per share declined to $19.10 from $19.98 as credit marks and foreign currency hedges weighed on results. For the fourth quarter of 2025, net investment income was $0.45 per share and net income was $0.23 per share. The company’s board declared a regular cash dividend of $0.42 per share for the first quarter of 2026, payable April 15, 2026 to shareholders of record on March 31, 2026. At year-end, Crescent BDC held $1.57 billion of investments across 184 portfolio companies, a weighted average yield on income-producing securities of 10.0%, and a debt-to-equity ratio of 1.25x, supported by $31.5 million of cash and $242.0 million of undrawn credit capacity.
Texas County & District Retirement System reports a significant passive stake in Crescent Capital BDC, Inc. It beneficially owns 5,001,752 shares of common stock, representing 13.50% of the class as of 12/31/2025.
The fund has sole power to vote and dispose of all 5,001,752 shares, with no shared voting or dispositive power. It certifies the position was acquired and is held in the ordinary course of business and not for the purpose of changing or influencing control of Crescent Capital BDC.
Texas County & District Retirement System reports a significant passive stake in Crescent Capital BDC, Inc. It beneficially owns 5,001,752 shares of common stock, representing 13.50% of the class as of 12/31/2025.
The fund has sole power to vote and dispose of all 5,001,752 shares, with no shared voting or dispositive power. It certifies the position was acquired and is held in the ordinary course of business and not for the purpose of changing or influencing control of Crescent Capital BDC.